Despite a challenging 2025, Giverny Capital's latest investor letter highlights Charles Schwab as a key portfolio contributor, projecting sustained growth for the financial giant as market dynamics evolve.
Ukrainian President Zelenskiy notes a 24-hour pause in targeted Russian strikes on energy grids, yet civilian casualties mount in frontline regions. The reported lull follows a disputed, short-term truce brokered by the U.S., as both sides prepare for talks in Abu Dhabi.
Brooke Day died after her backpack became entangled in a gondola lift at Tsugaike Mountain Resort, leading to a fatal cardiac arrest, highlighting rare but critical safety concerns.
Achieving a comfortable, $50,000-a-year retirement lifestyle is a common goal for many Americans. We break down the savings target, the critical role of Social Security, and the key factors that can make this financial milestone more attainable.
Amid persistent inflation and shifting trade policies, building a robust financial safety net is more crucial than ever. Experts outline actionable steps to grow your savings, from debt management to smart account allocation.
Freshly released documents from the Epstein files include a 2009 email from Sarah Ferguson, the Duchess of York, congratulating the convicted sex offender on the birth of a child—a claim that revives long-standing speculation about a potential secret heir to his fortune.
Pharmaceutical giant Eli Lilly enters a strategic collaboration potentially worth up to $1.93 billion with biotech firm Repertoire Immune Medicines, aiming to develop precision treatments for autoimmune diseases that move beyond broad immunosuppression.
As mortgage rates fluctuate and ambitious policy ideas emerge, economists warn that financing tweaks cannot solve the core issue: a chronic shortage of homes.
Barclays raises its price target on NorthWestern Energy Group (NWE) to $62, citing solid quarterly performance and strategic moves, including a pending merger with Black Hills Corporation, as the regulated utility reaffirms its long-term growth outlook.
UBS analyst Peter Grom increased his price target for Kimberly-Clark (KMB) to $110, citing steady core performance despite lingering Kenvue-related uncertainties, after the consumer goods giant reported better-than-expected quarterly profit driven by cost discipline and resilient demand.
Scotiabank has lowered its price target for Comcast (CMCSA), reflecting ongoing pressure in its core broadband business as the media giant reports higher-than-expected customer losses in Q4 and faces fierce competition from fiber and fixed-wireless rivals.
A new mandatory scheme requires all UK fuel stations to report price changes within 30 minutes, with data fed to comparison apps. The government-backed initiative aims to boost competition and save households an estimated £40 annually.
In Zimbabwe, where formal employment is scarce and medical costs are prohibitive, a stark financial choice is being made: affordable funeral policies are vastly outpacing health insurance, reflecting a cultural prioritization of dignified burials over accessible healthcare.
The aunt and cousin of Mexico's Secretary of Public Education, Mario Delgado, were fatally shot in their Colima home. Authorities later killed three suspects in a confrontation, highlighting the persistent violence plaguing the region.
The ninth edition of the Istanbul Fashion Connection (IFCO) is poised to gather an estimated 30,000 trade visitors and 400 exhibitors this February, highlighting Turkey's expanding influence in the global apparel sourcing landscape.
Alphabet's self-driving unit Waymo is in advanced talks to secure a massive $16 billion funding round, potentially valuing the company at around $110 billion, as competition in the robotaxi market intensifies.
Oracle announces plans to raise up to $50 billion in 2026 through debt and equity to massively expand its cloud data centers, aiming to meet surging demand from AI leaders like Nvidia, OpenAI, and xAI.
While investors chase AI and big tech, a niche biotech firm focused on rare genetic obesity disorders has quietly delivered staggering returns, with Wall Street seeing further 40% upside. Rhythm Pharmaceuticals' targeted approach and upcoming catalysts have analysts bullish, despite its relative anonymity.
Newly released figures reveal a sharp 111% increase in unauthorized drone activity near UK defence sites in 2025, prompting an expansion of military powers to counter the aerial threat.
Cogent Biosciences secures FDA Breakthrough Therapy Designation and enters the Real-Time Oncology Review program for its lead drug candidate bezuclastinib in gastrointestinal stromal tumors (GIST), marking significant regulatory momentum for the biotech firm.
